News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

First-half Business Figures For 2014:Sartorius AG Increases Order Intake, Sales Revenue And Profit


7/22/2014 4:02:27 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GOETTINGEN, Germany--(BUSINESS WIRE)--Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment supplier, successfully closed the first half of 2014 with significant gains. Consolidated order intake grew 8.9% in constant currencies; Group sales revenue rose 7.8%. Operating profit1) for the Group also climbed 4.8%; its respective margin after six months was 19.1%. Based on these solid first-half results, Sartorius confirms its Group forecast for the full year of 2014, which projects currency-adjusted growth in sales of 8% to 10% and an increase in its EBITDA margin to approximately 20.0%.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES